Efficacy in the ESWT and VED groups was excellent in 10% and 13.3%, respectively, and moderate in 63.3% and 53.3%, respectively. The treatment success rate in the ESWT and VED groups was 73.3% and 67.7%, respectively. This review includes all published preclinical and clinical studies of ESWT of the penis with the evaluation of the technical differences of the 6 ESWT devices and personal experiences with these 6 devices in ED and EP. The main outcome measures were the success rates in ED (International Index of Erectile Function-Change in Erectile Function, Conversion of Non-Responsive Phosphodiesterase Type 5 Inhibitors) and EP (Change in Plaque Deviation and Size), Differences in Energy Sources Used and Flow Densities energy (EFD).
Studies have shown that low-energy shockwave therapy can improve the response to oral medications for erectile dysfunction. It can also provide some return of spontaneous erections by increasing blood flow to the penis. Ramasamy and colleagues recently completed a phase II trial to analyze the MoreNova shockwave therapy device, manufactured by Direx. Shockwave therapy seems to work best for men with vasculogenic erectile dysfunction, which is a blood vessel disorder that affects blood flow to penile tissue.
According to several well-published studies and doctors, there have been no reported negative effects of penile shockwave therapy for the treatment of erectile dysfunction. We present our own preliminary experiences with low-intensity extracorporeal shock wave therapy in 160 patients who did not respond to ED and 190 patients with PD with success rates of 45% and 47%, respectively. On the positive side, shockwave therapy is different from other treatment options for ED, as it offers a possible cure for ED. It produces a shock that is very superficial and of insufficient energy to do anything on any type of scar tissue on the penis.
There is zero point zero medical literature that supports the use of this type of shock wave therapy for erection problems, Dr. Hatzichristodoulou, who conducted the first prospective placebo-controlled study of shockwave therapy in patients with Peyronie's disease while he was a medical student 17 years ago, says there are three placebo-controlled studies available worldwide on this treatment modality and all show that shock wave treatment in Peyronie's disease is effective in treating penile pain, but it does not improve or correct the curvature of the penis. Wave therapy is a non-invasive procedure that has been shown to improve certain types of erectile dysfunction. All patients undergoing low-intensity penile shockwave therapy should be advised that the treatment is The first identification of the effects of shock waves on human tissues was when underwater bombs exploded that caused damage to lung tissues near shipwrecked people despite that there were no external signs of skin damage.
Although the literature on the positive effects of low-intensity extracorporeal shockwave therapy on the penis is substantial, there are substantial differences with respect to energy sources and extracorporeal shock wave therapy (ESWT) devices. The European Urological Association's guide to erectile dysfunction recommends the use of low-intensity shockwave therapy in patients with mild organic erectile dysfunction or in patients with poor response to phosphodiesterase type 5 (PDE) inhibitors, according to Dr. effective and safe, but more research is needed to identify potential risks and the best treatment protocols for people with erectile dysfunction. To date, 11 randomized controlled studies have been conducted investigating the effects of penile shockwave therapy on erectile function.